Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Immucell (ICCC) over the last 15 years, with Q3 2025 value amounting to 0.6.

  • Immucell's Asset Utilization Ratio rose 3445.05% to 0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6, marking a year-over-year increase of 3445.05%. This contributed to the annual value of 0.6 for FY2024, which is 5122.6% up from last year.
  • According to the latest figures from Q3 2025, Immucell's Asset Utilization Ratio is 0.6, which was up 3445.05% from 0.61 recorded in Q2 2025.
  • In the past 5 years, Immucell's Asset Utilization Ratio ranged from a high of 0.61 in Q1 2025 and a low of 0.28 during Q4 2023
  • Its 5-year average for Asset Utilization Ratio is 0.44, with a median of 0.43 in 2021.
  • In the last 5 years, Immucell's Asset Utilization Ratio plummeted by 3115.46% in 2023 and then soared by 11550.89% in 2024.
  • Over the past 5 years, Immucell's Asset Utilization Ratio (Quarter) stood at 0.43 in 2021, then fell by 6.22% to 0.41 in 2022, then crashed by 31.15% to 0.28 in 2023, then skyrocketed by 115.51% to 0.6 in 2024, then decreased by 0.5% to 0.6 in 2025.
  • Its Asset Utilization Ratio was 0.6 in Q3 2025, compared to 0.61 in Q2 2025 and 0.61 in Q1 2025.